Table 1 (cont'd)
Pt. No.
& sex
Age
1979
Est.
thyroid
dose
(rads)
Thyroid Nodularities
Age at
detection
Surgery
Diagnosis
Hypofunction
TSH (uU/d1)
(c) Rongelap exposed at age >18
18 F
64 F
4M
45
55
63
335
335
335
71 F
34 F
66 F
52
70
55
335
335
335
78 F662
34
4]
Cleve. '69
Bost. '65
Papillary Ca
Papillary Ca
335
6.0, 7.0
6.6, 8.8
55
Cleve.
'79
Adenomatous nod.
Cleve. '72
Cleve. ‘81
Adenomatous nod.
Occult Pap. Ca
6.5, 7.0
6.3, 8.3
(d) Ailingnae exposed at age <10
8 F
53 F
26
33
450
320
18
28
(e) Ailingnae exposed at age 10-18:
and adenomatous nod.
NONE
(f) Ailingnae exposed at age >18
51 F
45 ¥F
50
57
135
135
45
51
Cleve. '74
Cleve. '73
59 F
-—
135
53
Bost.
16 M
64
41 M
69
135
'66
135
Adenoma
Adenomatous nod.
Nodule
Adenomatous nod.
(died '68, age 54)
6.4, 6.5
(g) Utirik exposed at age <10
2160 F
2154 F
29
31
80
75
25
28
Cleve.
‘75
2147 F
2239 F
2132 F
26
28
27
90
80
80
25
28
27
Cleve. '79
Cleve. ‘81
Cleve. ‘81
Papillary Ca
Nodule
reduced '79
Adenomatous nod.
"
"
"
"
Cleve. '76
Adenoma
(h) Utirik exposed at age 10-18
2229 F
2150 M
43
37
54
33
32
Cleve.
2236 M
36
55
34
Hono.
31
'69
‘78
~ 126 -
Papillary Ca
vs. atypical adenoma
Adenoma